Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis

Pediatric Research

Volumn 58, Issue 5, 2005, Pages 903-907

  Schmitt Grohé, Sabina ^a   Hippe, Valerie ^a   Igel, Michael ^a   Von Bergmann, Karl ^a   Posselt, Heinz G ^b   Krahl, Andreas ^b   Smaczny, Christina ^b   Wagner, Thomas O F ^b   Nikolazik, Wilfried ^c   Schubert, Ralf ^b   Lentze, Michael J ^a   Zielen, Stefan ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BLOOD; CHEMOLUMINESCENCE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; FAT INTAKE; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRIACYLGLYCEROL BLOOD LEVEL; VITAL CAPACITY;

ACUTE-PHASE PROTEINS; ADOLESCENT; CARRIER PROTEINS; CHILD; CYSTIC FIBROSIS; CYTOKINES; FEMALE; HUMANS; LIPOPROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MUTATION; RESPIRATORY FUNCTION TESTS;

EID: 27144479203     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000182598.98167.24     Document Type: Article

References (22)

1. Chmiel JF, Berger M, Konstan MW 2002 The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 23:5-27
2. Steinkamp G, Wiedemann B 2002 Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 57:596-601
3. Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau SM 1985 Fatty acid abnormalities in cystic fibrosis. Pediatr Res 19:104-109
4. Hubbard VS, Dunn GD, di Sant'Agnese PA 1977 Abnormal fatty acid composition of plasma-lipids in cystic fibrosis. A primary and secondary defect? Lancet 2:1302-1304
5. Lloyd-Still JD, Johnson SB, Holman RT 1981 Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 34:1-7
6. Wurfel MM, Wright SD 1997 Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J Immunol 158:3925-3934
7. Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H 1993 Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 61:5140-5146
8. Harris HW, Grunfeld C, Feingold KR, Rapp JH 1990 Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86:696-702
9. Netea MG, de Bont N, Demacker PN, Kullberg BJ, Jacobs LE, Verver-Jansen TJ, Stalenhoef AF, Van der Meer JW 1998 Lipoprotein (a) inhibits lipopolysaccharide-induced tumor necrosis alpha production by human mononuclear cells. Infect Immun 66:2365-2367
10. Martin TR 2000 Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 23:128-132
11. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C 1997 Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 3899:742-745
12. Shwachman H, Kulczycki LL 1958 Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. Am J Dis Child 96:6-15
13. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein CHOL in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
14. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Buurman WA, Wouters EF 2001 Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 56:721-726
15. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD 1994 Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts a as cofactor in the neutralization of LPS. J Exp Med 180:1025-1035
16. Ulevitch RJ, Johnnston AR, Weinstein DB 1981 New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 67:827-837
17. Baumberger C, Ulevitch RJ, Dayer JM 1991 Modulation of endotoxic activity of lipopolysaccharide by high density lipoprotein. Pathobiology 59:378-383
18. Schmitt-Grohé S, Naujoks C, Bargon J, Wagner TO, Schubert R, Hippe V, Zielen S 2005 Interleukin-8 in whole blood and clinical status in cystic fibrosis. Cytokine 29:18-23
19. Hollingworth JW, Chen BJ, Brass DM, Berman KG, Cook DN, Schwartz DA 2004 Hematopoetic expression of TLR4 is sufficient for neutrophil recruitment to the airspace following inhalation of lipopolysaccharide. Am J Respir Crit Care Med 169(7):A559
20. Levy E, Gurbindo C, Lacaille F, Paradis K, Thibault L, Seidman E 1993 Circulating tumor necrosis factor-α levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 34:162-166
21. Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G 1982 Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 100:857-862
22. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP 2004 Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560-569